J. Matthew Hutzler, PhD

Matt Hutzler brings nearly two decades of relevant experience in the core pharmaceutical R&D discipline of DMPK. After positions of increasing responsibility as a DMPK project lead at Pfizer and Boehringer-Ingelheim, he spent seven years with Q2-Solutions (IQVIA) as a director and site head.

Matt has seen a lot of drug discovery real estate: very early target ID and validation programs, chemical series optimization and pharmacology proof-of-concept programs, and drug candidate nominating and IND-seeking programs. Because of the broad reach of DMPK across the discovery to development continuum, Matt provides leadership for project teams in several therapeutic areas, including inflammation, immunology, oncology, cardiovascular-metabolic, and respiratory disease.

Back to Team